MDCX Medicus Pharma Ltd. Common Stock
Healthcare$0.30+4.90%ClosedMarket Cap: $6.6M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
6.68
P/S
0.00
EV/EBITDA
-0.01
DCF Value
$0.08
FCF Yield
-354.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-4086.3%
ROA
-497.3%
ROIC
-2193.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-6.3M | $-6.6M | $— | — |
| Q4 null | $0.00 | NaN% | $-7.8M | $-8.2M | $— | — |
| FY null | $0.00 | NaN% | $-18.4M | $-25.4M | $— | — |
| Q3 null | $0.00 | NaN% | $-15.4M | $-16.0M | $— | — |
| Q2 null | $0.00 | NaN% | $-6.0M | $-6.2M | $— | — |
| Q1 null | $0.00 | NaN% | $-5.1M | $-5.1M | $— | — |
| Q4 null | $0.00 | NaN% | $-2.4M | $-2.3M | $— | — |
| FY null | $0.00 | NaN% | $-11.2M | $-11.2M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-3.0M | $-3.0M | $— | — |
| Q2 null | $0.00 | NaN% | $-4.0M | $-4.1M | $— | — |
| Q1 null | $0.00 | NaN% | $-1.8M | $-1.8M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-1.8M | $-2.5M | $-1.41 | — |